Hyperkalemia in chronic kidney disease
Main Author: | |
---|---|
Publication Date: | 2020 |
Format: | Article |
Language: | eng |
Source: | Revista da Associação Médica Brasileira (Online) |
Download full: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302020001300031 |
Summary: | SUMMARY Hyperkalemia is a frequent finding in patients with chronic kidney disease (CKD). This increase in serum potassium levels is associated with decreased renal ion excretion, as well as the use of medications to reduce the progression of CKD or to control associated diseases such as diabetes mellitus and heart failure. Hyperkalemia increases the risk of cardiac arrhythmia episodes and sudden death. Thus, the control of potassium elevation is essential for reducing the mortality rate in this population. Initially, the management of hyperkalemia includes orientation of low potassium diets and monitoring of patients' adherence to this procedure. It is also important to know the medications in use and the presence of comorbidities to guide dose reduction or even temporary withdrawal of any of the potassium retention-related drugs. And finally, the use of potassium binders is indicated in both acute episodes and chronic hyperkalemia. |
id |
AMB-1_8bb90d445f839c1274ecc19a0a21a221 |
---|---|
oai_identifier_str |
oai:scielo:S0104-42302020001300031 |
network_acronym_str |
AMB-1 |
network_name_str |
Revista da Associação Médica Brasileira (Online) |
repository_id_str |
|
spelling |
Hyperkalemia in chronic kidney diseaseChronic renal diseaseHyperkalemiaRenin-angiotensin-aldosterone system inhibitorsCalcium polystyrene sulfonatePartomerSodium zirconium cyclosilicateSUMMARY Hyperkalemia is a frequent finding in patients with chronic kidney disease (CKD). This increase in serum potassium levels is associated with decreased renal ion excretion, as well as the use of medications to reduce the progression of CKD or to control associated diseases such as diabetes mellitus and heart failure. Hyperkalemia increases the risk of cardiac arrhythmia episodes and sudden death. Thus, the control of potassium elevation is essential for reducing the mortality rate in this population. Initially, the management of hyperkalemia includes orientation of low potassium diets and monitoring of patients' adherence to this procedure. It is also important to know the medications in use and the presence of comorbidities to guide dose reduction or even temporary withdrawal of any of the potassium retention-related drugs. And finally, the use of potassium binders is indicated in both acute episodes and chronic hyperkalemia.Associação Médica Brasileira2020-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302020001300031Revista da Associação Médica Brasileira v.66 suppl.1 2020reponame:Revista da Associação Médica Brasileira (Online)instname:Associação Médica Brasileira (AMB)instacron:AMB10.1590/1806-9282.66.s1.31info:eu-repo/semantics/openAccessWatanabe,Renatoeng2020-01-08T00:00:00Zoai:scielo:S0104-42302020001300031Revistahttps://ramb.amb.org.br/ultimas-edicoes/#https://old.scielo.br/oai/scielo-oai.php||ramb@amb.org.br1806-92820104-4230opendoar:2020-01-08T00:00Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB)false |
dc.title.none.fl_str_mv |
Hyperkalemia in chronic kidney disease |
title |
Hyperkalemia in chronic kidney disease |
spellingShingle |
Hyperkalemia in chronic kidney disease Watanabe,Renato Chronic renal disease Hyperkalemia Renin-angiotensin-aldosterone system inhibitors Calcium polystyrene sulfonate Partomer Sodium zirconium cyclosilicate |
title_short |
Hyperkalemia in chronic kidney disease |
title_full |
Hyperkalemia in chronic kidney disease |
title_fullStr |
Hyperkalemia in chronic kidney disease |
title_full_unstemmed |
Hyperkalemia in chronic kidney disease |
title_sort |
Hyperkalemia in chronic kidney disease |
author |
Watanabe,Renato |
author_facet |
Watanabe,Renato |
author_role |
author |
dc.contributor.author.fl_str_mv |
Watanabe,Renato |
dc.subject.por.fl_str_mv |
Chronic renal disease Hyperkalemia Renin-angiotensin-aldosterone system inhibitors Calcium polystyrene sulfonate Partomer Sodium zirconium cyclosilicate |
topic |
Chronic renal disease Hyperkalemia Renin-angiotensin-aldosterone system inhibitors Calcium polystyrene sulfonate Partomer Sodium zirconium cyclosilicate |
description |
SUMMARY Hyperkalemia is a frequent finding in patients with chronic kidney disease (CKD). This increase in serum potassium levels is associated with decreased renal ion excretion, as well as the use of medications to reduce the progression of CKD or to control associated diseases such as diabetes mellitus and heart failure. Hyperkalemia increases the risk of cardiac arrhythmia episodes and sudden death. Thus, the control of potassium elevation is essential for reducing the mortality rate in this population. Initially, the management of hyperkalemia includes orientation of low potassium diets and monitoring of patients' adherence to this procedure. It is also important to know the medications in use and the presence of comorbidities to guide dose reduction or even temporary withdrawal of any of the potassium retention-related drugs. And finally, the use of potassium binders is indicated in both acute episodes and chronic hyperkalemia. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-01-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302020001300031 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302020001300031 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/1806-9282.66.s1.31 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Associação Médica Brasileira |
publisher.none.fl_str_mv |
Associação Médica Brasileira |
dc.source.none.fl_str_mv |
Revista da Associação Médica Brasileira v.66 suppl.1 2020 reponame:Revista da Associação Médica Brasileira (Online) instname:Associação Médica Brasileira (AMB) instacron:AMB |
instname_str |
Associação Médica Brasileira (AMB) |
instacron_str |
AMB |
institution |
AMB |
reponame_str |
Revista da Associação Médica Brasileira (Online) |
collection |
Revista da Associação Médica Brasileira (Online) |
repository.name.fl_str_mv |
Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB) |
repository.mail.fl_str_mv |
||ramb@amb.org.br |
_version_ |
1754212835632611328 |